Cancer Research 09 AM Call for Abstracts  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foster, K. W.
Right arrow Articles by Ruppert, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foster, K. W.
Right arrow Articles by Ruppert, J. M.
[Cancer Research 60, 6488-6495, November 15, 2000]
© 2000 American Association for Cancer Research


Tumor Biology

Increase of GKLF Messenger RNA and Protein Expression during Progression of Breast Cancer1

K. Wade Foster, Andra R. Frost, Peggy McKie-Bell, Chin-Yu Lin, Jeffrey A. Engler, William E. Grizzle and J. Michael Ruppert2

Department of Biochemistry and Molecular Genetics [K. W. F., J. A. E., J. M. R.], Department of Pathology [A. R. F., W. E. G.], Division of Hematology/Oncology, Department of Medicine [P. M-B., J. M. R.], Medical Statistics Section, Department of Medicine [C-Y. L.], and Oral Cancer Research Center and Comprehensive Cancer Center [J. A. E., W. E. G., J. M. R.], University of Alabama at Birmingham School of Medicine, Birmingham, Alabama 35294-3300

Genetic alterations found in carcinomas can alter specific regulatory pathways and provide a selective growth advantage by activation of transforming oncogenes. A subset of these genes, including wild-type alleles of GLI or c-MYC, and activated alleles of RAS or ß-catenin, exhibit transforming activity when expressed in diploid epithelial RK3E cells in vitro. By in vitro transformation of these cells, the zinc finger protein GKLF/KLF-4 was recently identified as a novel oncogene. Although GKLF is normally expressed in superficial, differentiating epithelial cells of the skin, oral mucosa, and gut, expression is consistently up-regulated in dysplastic epithelium and in squamous cell carcinoma of the oral cavity. In the current study, we used in situ hybridization, Northern blot analysis, and immunohistochemistry to detect GKLF at various stages of tumor progression in the breast, prostate, and colon. Overall, expression of GKLF mRNA was detected by in situ hybridization in 21 of 31 cases (68%) of carcinoma of the breast. Low-level expression of GKLF mRNA was observed in morphologically normal (uninvolved) breast epithelium adjacent to tumor cells. Increased expression was observed in neoplastic cells compared with adjacent uninvolved epithelium for 14 of 19 cases examined (74%). Ductal carcinoma in situ exhibited similar expression as invasive carcinoma, suggesting that GKLF is activated prior to invasion through the basement membrane. Expression as determined by Northern blot was increased in most breast tumor cell lines and in immortalized human mammary epithelial cells when these were compared with finite-life span human mammary epithelial cells. Alteration of GKLF expression was confirmed by the use of a novel monoclonal antibody that detected the protein in normal and neoplastic tissues in a distribution consistent with localization of the mRNA. In contrast to most breast tumors, expression of GKLF in tumor cells of colorectal or prostatic carcinomas was reduced or unaltered compared with normal epithelium. The results demonstrate that GKLF expression in epithelial compartments is altered in a tissue-type specific fashion during tumor progression, and suggest that increased expression of GKLF mRNA and protein may contribute to the malignant phenotype of breast tumors.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
S. D. Cho, S. Chintharlapalli, M. Abdelrahim, S. Papineni, S. Liu, J. Guo, P. Lei, A. Abudayyeh, and S. Safe
5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells
Mol. Cancer Ther., July 1, 2008; 7(7): 2109 - 2120.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Yoshida, K. H. Kaestner, and G. K. Owens
Conditional Deletion of Kruppel-Like Factor 4 Delays Downregulation of Smooth Muscle Cell Differentiation Markers but Accelerates Neointimal Formation Following Vascular Injury
Circ. Res., June 20, 2008; 102(12): 1548 - 1557.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Wei, M. Kanai, Z. Jia, X. Le, and K. Xie
Kruppel-like Factor 4 Induces p27Kip1 Expression in and Suppresses the Growth and Metastasis of Human Pancreatic Cancer Cells
Cancer Res., June 15, 2008; 68(12): 4631 - 4639.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Yang, S. R. Hamilton, A. Sood, T. Kuwai, L. Ellis, A. Sanguino, G. Lopez-Berestein, and D. D. Boyd
The Previously Undescribed ZKSCAN3 (ZNF306) Is a Novel "Driver" of Colorectal Cancer Progression
Cancer Res., June 1, 2008; 68(11): 4321 - 4330.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. Liu, H. Zhang, L. Zhu, L. Zhao, and Y. Dong
Kruppel-Like Factor 4 Is a Novel Mediator of Selenium in Growth Inhibition
Mol. Cancer Res., February 1, 2008; 6(2): 306 - 313.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. M. Evans, W. Zhang, X. Chen, J. Yang, K. K. Bhakat, and C. Liu
Kruppel-like Factor 4 Is Acetylated by p300 and Regulates Gene Transcription via Modulation of Histone Acetylation
J. Biol. Chem., November 23, 2007; 282(47): 33994 - 34002.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
R. Behr, C. Deller, M. Godmann, T. Muller, M. Bergmann, R. Ivell, and K. Steger
Kruppel-like factor 4 expression in normal and pathological human testes
Mol. Hum. Reprod., November 1, 2007; 13(11): 815 - 820.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
W. Ai, H. Zheng, X. Yang, Y. Liu, and T. C. Wang
Tip60 functions as a potential corepressor of KLF4 in regulation of HDC promoter activity
Nucleic Acids Res., September 25, 2007; 35(18): 6137 - 6149.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Wei, H. Xu, and D. Kufe
Human Mucin 1 Oncoprotein Represses Transcription of the p53 Tumor Suppressor Gene
Cancer Res., February 15, 2007; 67(4): 1853 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Suzuki, H. Watanabe, T. Mizutani, T. Sato, Y. Ohta, and T. Iguchi
Global Gene Expression in Mouse Vaginae Exposed to Diethylstilbestrol at Different Ages.
Experimental Biology and Medicine, May 1, 2006; 231(5): 632 - 640.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Wei, M. Kanai, S. Huang, and K. Xie
Emerging role of KLF4 in human gastrointestinal cancer
Carcinogenesis, January 1, 2006; 27(1): 23 - 31.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Y. Chen, X. Wang, Y. Zhou, G. Offner, and C.-C. Tseng
Destabilization of Kruppel-Like Factor 4 Protein in Response to Serum Stimulation Involves the Ubiquitin-Proteasome Pathway
Cancer Res., November 15, 2005; 65(22): 10394 - 10400.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. D. Graham, M. L. Yager, H. D. Hill, K. Byth, G. M. O'Neill, and C. L. Clarke
Altered Progesterone Receptor Isoform Expression Remodels Progestin Responsiveness of Breast Cancer Cells
Mol. Endocrinol., November 1, 2005; 19(11): 2713 - 2735.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Wei, W. Gong, M. Kanai, C. Schlunk, L. Wang, J. C. Yao, T.-T. Wu, S. Huang, and K. Xie
Drastic Down-regulation of Kruppel-Like Factor 4 Expression Is Critical in Human Gastric Cancer Development and Progression
Cancer Res., April 1, 2005; 65(7): 2746 - 2754.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Li, J. McClintick, L. Zhong, H. J. Edenberg, M. C. Yoder, and R. J. Chan
Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4
Blood, January 15, 2005; 105(2): 635 - 637.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
M Lacroix, R-A Toillon, and G Leclercq
Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics
Endocr. Relat. Cancer, September 1, 2004; 11(3): 497 - 522.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Y. Pandya, L. I. Talley, A. R. Frost, T. J. Fitzgerald, V. Trivedi, M. Chakravarthy, D. C. Chhieng, W. E. Grizzle, J. A. Engler, H. Krontiras, et al.
Nuclear Localization of KLF4 Is Associated with an Aggressive Phenotype in Early-Stage Breast Cancer
Clin. Cancer Res., April 15, 2004; 10(8): 2709 - 2719.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Liu, S. Sinha, and G. Owens
A Transforming Growth Factor-{beta} Control Element Required for SM {alpha}-Actin Expression in Vivo Also Partially Mediates GKLF-dependent Transcriptional Repression
J. Biol. Chem., November 28, 2003; 278(48): 48004 - 48011.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. K. Richer, B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells
J. Biol. Chem., February 8, 2002; 277(7): 5209 - 5218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Chen, D. C. Johns, D. E. Geiman, E. Marban, D. T. Dang, G. Hamlin, R. Sun, and V. W. Yang
Kruppel-like Factor 4 (Gut-enriched Kruppel-like Factor) Inhibits Cell Proliferation by Blocking G1/S Progression of the Cell Cycle
J. Biol. Chem., August 3, 2001; 276(32): 30423 - 30428.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Bieker
Kruppel-like Factors: Three Fingers in Many Pies
J. Biol. Chem., September 7, 2001; 276(37): 34355 - 34358.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.